AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Epbriv 0.44mg Injection

Prescription Icon
Prescription Required

Marketer

Hetero Healthcare Limited

Salt Composition

Eribulin Mesylate (0.44mg)

Overview Epbriv 0.44mg Injection

Erbitux 0.44mg Injection is indicated for advanced breast cancer treatment in adults. It's employed in patients whose cancer has metastasized, following prior anticancer therapies. Erbitux 0.44mg Injection may be administered alone or in conjunction with other medications within a combination chemotherapy regimen. Intravenous administration is strictly under medical supervision; dosage and frequency are determined by your physician based on individual needs and may vary. Adhere precisely to your doctor's instructions; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may take weeks or months to manifest; discontinue only under medical guidance. Common side effects include fatigue, alopecia, nausea, and bowel irregularities. This medication can decrease blood cell counts (including red blood cells), increasing infection risk. Regular blood tests are essential to monitor blood cell levels, along with cardiac, hepatic, uric acid, and electrolyte levels. Peripheral neuropathy, characterized by numbness, tingling, or pins and needles in the extremities, may occur; report persistent or bothersome symptoms to your doctor. Prior to treatment, disclose any pre-existing heart, liver, or kidney conditions, and all current medications, particularly those for infections. Interactions with other drugs are possible; comprehensive medication disclosure is crucial. Erbitux is contraindicated during pregnancy and lactation. Reliable contraception is mandatory for both partners throughout treatment to prevent conception.

Primary Ingredients of Epbriv 0.44mg Injection

No text provided. Please provide the text you want me to rephrase.

Uses of Epbriv 0.44mg Injection

Breast cancer with distant spread

Major Benefits of Epbriv 0.44mg Injection:

The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Epbriv 0.44mg Injection:

  • Anemia (low number of red blood cells)
  • Weakness
  • Hair loss
  • Nausea
  • Constipation
  • Decreased white blood cell count
  • Fatigue
  • Peripheral neuropathy (tingling and numbness of feet and hand)

How to use Epbriv 0.44mg Injection:

This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.

How Epbriv 0.44mg Injection works:

Epb riv 0.44mg Injection is a cancer treatment that disrupts microtubule function, essential for cancer cell division and proliferation. This disruption halts cancer cell growth, ultimately leading to their demise.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

The interaction of alcohol with Epbriv 0.44mg Injection is undetermined. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Epbriv 0.44mg Injection during pregnancy is contraindicated due to established fetal risks. Nevertheless, in exceptional life-threatening circumstances, a physician might deem its use justifiable if the potential advantages outweigh the hazards. Physician consultation is essential.

Breast feedingBreast feedingUNSAFE

Administration of Epbriv 0.44mg Injection is contraindicated while breastfeeding due to potential infant toxicity.

DrivingDrivingUNSAFE

Epbriv 0.44mg Injection can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneyCAUTION

Individuals with impaired kidney function should exercise caution when using Epbriv 0.44mg Injection. Dosage modification of Epbriv 0.44mg Injection might be necessary. Physician consultation is recommended.

LiverLiverCAUTION

Patients with hepatic impairment should use Epbriv 0.44mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Epbriv 0.44mg Injection :

NA

Facts to Know About Epbriv 0.44mg Injection

LabelValue
Chemical Type Halichondrin B analog
Developing Habits No.
Treatment Category Cancer Medications
Active Class Non-Taxane Microtubule Inhibitors

FAQs on Epbriv 0.44mg Injection

Epbriv 0.44mg Injection may cause hair loss, a side effect that can vary in severity and may be reversible. Discuss any hair loss concerns with your doctor.
Epbriv 0.44mg Injection is typically administered on days 1 and 8 of a 21-day treatment cycle. Treatment length varies individually, with the total number of cycles determined by your physician. Based on blood test results, your doctor may postpone or adjust your dosage.
A doctor or healthcare professional will administer Epbriv 0.44mg Injection intravenously over 2 to 5 minutes. Dosage, determined by your body surface area (m²), is calculated from your weight and height and may be adjusted based on your blood test results or other factors. Following administration, a saline flush is recommended to ensure complete delivery of the Epbriv 0.44mg Injection.
Epbriv 0.44mg Injection carries serious risks, including a dangerously low white blood cell count (neutropenia), potentially causing fatal infections. Numbness, tingling, or pain in the hands and feet (peripheral neuropathy) is also possible; this common side effect can be severe. Use during pregnancy may harm the baby.
Women of childbearing age must use effective contraception during and for three months after Epbriv 0.44mg Injection treatment. This medication can cause serious birth defects and should not be used during pregnancy unless absolutely necessary after careful consideration of risks to both mother and baby.
Handle Epbriv 0.44mg Injection with care, avoiding contact with skin, eyes, mouth, or nose. Gloves, goggles, and protective clothing are recommended. In case of contact, immediately wash affected skin thoroughly with soap and water; rinse eyes, mouth, or nose thoroughly with water. Pregnant personnel should not handle this injection.
Epbriv 0.44 mg Injection can be diluted with up to 100 mL of 0.9% sodium chloride solution, but not with 5% dextrose. Administration must be supervised by an oncologist and performed by a qualified healthcare professional.
Epbriv 0.44mg Injection
19,008
MRP 22,000
13% off